Stock listing

Frankfurt:2TK Eledon Pharmaceuticals, Inc. Aktie

German listing (Frankfurt) of Eledon Pharmaceuticals, Inc. · home listing NASDAQ:ELDN

Follow Eledon Pharmaceuticals, Inc. into a list and get an email when it puts out news.

Share price · FWB:2TK

€2.60 EUR +0.68 (+35.4%)

Close on Oct 30, 2026

Day range
€2.60 – €2.60 EUROct 30, 2026
Market cap
€211.3M EURAt the close on Oct 30, 2026 · price × 81.26M shares outstanding
Eledon Pharmaceuticals, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:ELDN · Home$2.77 USD-0.27 (-8.9%)1,264,247$3.009$3.04$2.745$3.04Close on Oct 30, 2026
Frankfurt:2TK€2.60 EUR+0.68 (+35.4%)—€2.60€2.60€2.60€1.92Close on Oct 30, 2026
Ticker
Frankfurt:2TK
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Eledon Pharmaceuticals (NASDAQ:ELDN) Q1 2024 Earnings Call

    Thu, May 09, 2024 · 4:30 PM ET

    Watch Transcript
  • Eledon Pharmaceuticals (NASDAQ:ELDN) Q1 2023 Earnings Call

    Thu, May 11, 2023 · 4:30 PM ET

    Watch Transcript
  • Eledon Pharmaceuticals (NASDAQ:ELDN) Q4 2022 Earnings Call

    Thu, Mar 30, 2023 · 4:30 PM ET

    Watch Transcript

Latest news

All Eledon Pharmaceuticals, Inc. news

Decks

Eledon Pharmaceuticals, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
25 in the last 12 months · 96 in all · newest Oct 26, 2026 · oldest 2021
Calls
10 calls with a replay · 10 with a transcript · latest May 9, 2024
Decks
7 decks · latest September 2026

Where Eledon Pharmaceuticals, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:ELDN · Home listingNASDAQUnited StatesUSD
BOATS:ELDNBOATSUnited StatesUSD
Lang & Schwarz:A2QL00Lang & SchwarzGermanyEUR
LS Exchange:A2QL00LS ExchangeGermanyEUR
Tradegate:2TKTradegateGermanyEUR
Dusseldorf:2TKDusseldorfGermanyEUR
Frankfurt:2TK · This pageFrankfurtGermanyEUR
Munich:2TKMunichGermanyEUR
Stuttgart:2TKStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Eledon Pharmaceuticals, Inc.